Select dining locations will be open for additional hours during the NOAC Conference at CU Boulder, July 29-Aug. 3.

Frail patients with atrial fibrillation who were switched to a newer NOAC agent had more bleeding than those left on older vitamin K antagonists, without any benefit in terms of thromboembolic events.

Concurrent use of amiodarone, fluconazole, rifampin, and phenytoin was associated with increased risk for major bleeding compared with the use of NOACs alone in a new study.

Cardiology > Strokes Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort — No excess brain bleeds in an Asian population receiving lytic therapy for stroke by Nicole Lou ...

NOAC treatment was more common in Europe in phase 2 than VKA (52.3 versus 37.8 percent, respectively); 6.0 and 3.8 percent of patients received antiplatelet treatment and no antithrombotic ...

In patients with atrial fibrillation undergoing PCI, antithrombotic regimens involving a vitamin K antagonist (VKA) plus dual antiplatelet therapy (DAPT) should be avoided, whereas use of a non-VKA ...

Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe, reveals research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by ...

Breakthrough Listen are working with the National Observatory of China and three telescopes to investigate life beyond Earth.

This study is limited because it is not randomized and patients receiving a NOAC could be systematically different from those treated with warfarin, Greenberg said. Nevertheless, “it at least suggests ...

Uninterrupted treatment with novel oral anticoagulants during catheter ablation of atrial fibrillation is safe, suggests new research. Continuation of NOAC therapy was not associated with ...

Patients would take their currently prescribed medication (vitamin K antagonist or NOAC) and be randomised to continuous or interrupted therapy during catheter ablation of AF.